Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

CBAY, FSLR, IPXL, SPWR

Published 07/19/2017, 07:56 AM
Updated 07/09/2023, 06:31 AM

Cymabay Therapeu (NASDAQ:CBAY), one of our swing trades, after announcing a secondary, and getting smacked to 4 3/4 Monday night, it opened at 5.50, ran up to 7.00, and closed up 96 cents, or 16%, to 6.94, on 5.1 million shares traded. There’s less than 2 days to cover on this one, so I’m not sure how far we can go. Let’s see if it will get up to Monday’s high at 7.77. If it surpasses that, I’m looking near 9.00 for the next target.

First Solar, Inc. (NASDAQ:FSLR) is also acting great, jumping 1.30, or 3%, to 44.02, on 2.9 million shares traded. From where it started, the breakout and pullback, I gave you something around the 33-4 range. It’s 4 waves up, and the fifth wave is underway. It may very well get an extension quickly to take this one up to the 47-8 zone. I don’t know whether it will extend much beyond that before it pulls back, but there is 5 days to cover, and that could fuel the fire.

Impax Laboratories Inc (NASDAQ:IPXL) gained 15 cents to 18.25, on 1.8 million shares traded on Tuesday. It has a left and right shoulder-type pattern that I’m really liking. It has had a nice move up, and a 3-wave corrective move. That’s wave one and two, and wave three is underway. I think wave three will get to 20 before it’s over, pulls back, and then runs into the low to mid 20’s. It has 4 days to cover short. I like the overall structure and look of this one. It has good technicals.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

SunPower Corporation (NASDAQ:SPWR) is acting great. Along with First Solar, we’re doing very well with our solar stocks. It popped on Tuesday, and was up 70 cents, or 7%, to 11.07, on 7.2 million shares traded. Although there was a gap, the target above the gap is about 12 1/2. It may pull back and consolidate at that point. I’m looking for 14 and 17 as the next targets.

On the long side, stocks included Applied Optoelectroics (NASDAQ:AAOI), Agenus Inc (NASDAQ:AGEN), Cymabay Therapeu (NASDAQ:CBAY), Eros International (NYSE:EROS), Amicus Therapeutics Inc (NASDAQ:FOLD), First Solar Inc (NASDAQ:FSLR), Impax Laboratories Inc (NASDAQ:IPXL), JinkoSolar Holding Company Limited (NYSE:JKS), Kemet Corporation (NYSE:KEM), Nektar Therapeutics (NASDAQ:NKTR), Nutanix Inc (NASDAQ:NTNX), Puma Biotechnology Inc (NASDAQ:PBYI), Quidel Corporation (NASDAQ:QDEL), Sodastream International Ltd (NASDAQ:SODA), SunPower Corporation (NASDAQ:SPWR), TRAVEL B.V. (TRVG), and Yirendai Ltd. (NYSE:YRD).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.